RA Capital Nexus Fund IV, L.P. insider trades: Hemab Therapeutics Holdings (COAG) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where RA Capital Nexus Fund IV, L.P. reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | COAG | ↑ Buy | 2,840,429 | $18.39 | $52.2M | Indirect | May 6, 2026 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other COAG insiders
Open-market trades in the last 12 months
About RA Capital Nexus Fund IV, L.P.'s insider trades
RA Capital Nexus Fund IV, L.P. is a director at Hemab Therapeutics Holdings (COAG). Since May 6, 2026, it has reported 1 open-market purchase worth $52.2M and no sales on SEC Form 4. In the last 12 months: 1 buy ($52.2M).
Its filings also include conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every COAG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.